WEAVER GREGORY L

Chief Financial Officer

WEAVER GREGORY L has filed 7 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Nov 13, 2026.

On the most recent filing, WEAVER GREGORY L is listed as Chief Financial Officer at Altimmune, Inc. Inside the rolling window, WEAVER GREGORY L reported 3 open-market purchases totaling $65K in ALT and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000 ALT shares on Apr 1, 2026, worth $31K.

Companies traded

Other insiders at ALT

Insider Buying

$65K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ALTPurchase$16KNov 13SEC ↗
ALTPurchase$31KApr 1SEC ↗
ALTPurchase$18KMar 9SEC ↗
Showing 1–3 of 3
1 / 1

Frequently asked questions

How many SEC Form 4 filings has WEAVER GREGORY L made?

WEAVER GREGORY L has filed 7 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.

Which companies does WEAVER GREGORY L trade?

WEAVER GREGORY L has filed SEC Form 4 disclosures for 1 company, including ALT.

When was WEAVER GREGORY L's most recent SEC Form 4 filing?

WEAVER GREGORY L's most recent SEC Form 4 filing on Tracefour is dated Nov 13, 2026.

What is WEAVER GREGORY L's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, WEAVER GREGORY L is listed as Chief Financial Officer.

What is WEAVER GREGORY L's total buy and sell value in the current window?

Inside the rolling retention window, WEAVER GREGORY L bought $65K and sold $0 based on SEC Form 4 filings.

What was WEAVER GREGORY L's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 10,000 ALT shares on 2026-04-01, worth $31K, per SEC Form 4 filings.